ProKidney Corp. (PROK) income statement
PROKNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$1.04−0.02 (-1.89%)
Close on Nov 20, 2026Market cap $314.42MP/E –Yield –
ProKidney Corp. financial ratios
See a number that looks wrong?